Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
45.62
+3.31 (7.82%)
Jul 28, 2026, 1:17 PM EDT - Market open
Eton Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 19.66 | 25.94 | 14.94 | 21.39 | 16.31 | 14.41 |
Cash & Short-Term Investments | 19.66 | 25.94 | 14.94 | 21.39 | 16.31 | 14.41 |
Cash Growth | 12.86% | 73.69% | -30.17% | 31.17% | 13.18% | -32.35% |
Accounts Receivable | 13.41 | 11.76 | 5.36 | 3.41 | 1.85 | 5.47 |
Inventory | 14.47 | 15.42 | 15.23 | 0.91 | 0.56 | 0.55 |
Other Current Assets | 5.71 | 7.46 | 5.49 | 1.13 | 1.29 | 3.18 |
Total Current Assets | 53.25 | 60.58 | 41.02 | 26.84 | 20 | 23.6 |
Net Property, Plant & Equipment | 0.67 | 0.64 | 0.21 | 0.15 | 0.26 | 0.22 |
Other Intangible Assets | 43.74 | 30.88 | 34.88 | 4.74 | 4.75 | 3.62 |
Other Long-Term Assets | 0.05 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 |
Total Assets | 97.71 | 92.11 | 76.12 | 31.74 | 25.03 | 27.47 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 13.49 | 10.98 | 4.17 | 1.85 | 1.77 | 1.77 |
Accrued Expenses | 18.89 | 18.73 | 15.78 | 9.01 | 3.66 | 1.37 |
Short-Term Debt | 11.81 | 8.79 | - | - | - | - |
Current Portion of Long-Term Debt | - | - | - | 5.38 | 1.03 | 1.42 |
Total Current Liabilities | 44.18 | 38.49 | 19.95 | 16.24 | 6.46 | 4.56 |
Long-Term Debt | 18.94 | 21.77 | 29.81 | - | 5.38 | 5.26 |
Long-Term Leases | 0.44 | 0.46 | 0.11 | 0.02 | 0.11 | 0.02 |
Other Long-Term Liabilities | 3.54 | 5.24 | 1.83 | - | - | - |
Total Long-Term Liabilities | 22.92 | 27.47 | 31.75 | 0.02 | 5.49 | 5.28 |
Total Liabilities | 67.1 | 65.96 | 51.7 | 16.26 | 11.95 | 9.84 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
Additional Paid-in Capital | 141.53 | 138.62 | 132.29 | 119.52 | 116.19 | 111.72 |
Retained Earnings | -110.94 | -112.49 | -107.89 | -104.07 | -103.13 | -94.11 |
Shareholders' Equity | 30.62 | 26.15 | 24.43 | 15.48 | 13.08 | 17.63 |
Total Liabilities & Equity | 97.71 | 92.11 | 76.12 | 31.74 | 25.03 | 27.47 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 31.19 | 31.02 | 29.92 | 5.4 | 6.52 | 6.7 |
Net Cash (Debt) | -11.53 | -5.08 | -14.98 | 15.99 | 9.78 | 7.71 |
Net Cash Growth | - | - | - | 63.44% | 26.85% | -45.52% |
Net Cash Per Share | -0.40 | -0.19 | -0.58 | 0.62 | 0.39 | 0.31 |
Book Value | 30.62 | 26.15 | 24.43 | 15.48 | 13.08 | 17.63 |
Book Value Per Share | 1.05 | 0.97 | 0.94 | 0.60 | 0.52 | 0.70 |
Tangible Book Value | -13.12 | -4.72 | -10.45 | 10.74 | 8.32 | 14.01 |
Tangible Book Value Per Share | -0.45 | -0.18 | -0.40 | 0.42 | 0.33 | 0.56 |